Effects of quercetin in preclinical models of Parkinson's disease: A systematic review
Basic & Clinical Pharmacology & Toxicology · 2024
DOI: 10.1111/bcpt.14011 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Basic & Clinical Pharmacology & Toxicology, 2024. Verfasst von Camila de Oliveira Vian und 5 weiteren Autor:innen. Beteiligte Einrichtung: Programa de Pós-graduação em Ciências Fisiológicas, Universidade Federal do Rio Grande (FURG), Rio Grande, Brazil. Hauptthemen laut MEDLINE: Antioxidants, Disease Models, Animal, Neuroprotective Agents, Oxidative Stress. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 97 Literaturangaben. Gefördert von: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - Brazil (CAPES) - Finance code 001, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.
Abstract (Originalsprache)
Parkinson's disease (PD) is a neurodegenerative disease that affects dopaminergic neurons, thus impairing dopaminergic signalling. Quercetin (QUE) has antioxidant and neuroprotective properties that are promising for the treatment of PD. This systematic review aimed to investigate the therapeutic effects of QUE against PD in preclinical models. The systematic search was performed in PubMed, Scopus and Web of Science. At the final screening stage, 26 articles were selected according to pre‐established criteria. Selected studies used different methods for PD induction, as well as animal models. Most studies used rats (73.08%) and mice (23.08%), with 6‐OHDA as the main strategy for PD induction (38.6%), followed by rotenone (30.8%). QUE was tested immersed in oil, nanosystems or in free formulations, in varied routes of administration and doses, ranging from 10 to 400 mg/kg and from 5 to 200 mg/kg in oral and intraperitoneal administrations, respectively. Overall, evidence from published data suggests a potential use of QUE as a treatment for PD, mainly through the inhibition of oxidative stress, neuroinflammatory response and apoptotic pathways.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Programa de Pós-graduação em Ciências Fisiológicas, Universidade Federal do Rio Grande (FURG), Rio Grande, Brazil.
- Laboratório de Neurociências, Instituto de Ciências Biológicas, FURG, Rio Grande, Brazil.
- Programa de Pós-Graduação em Biociências e Saúde, Universidade do Oeste de Santa Catarina (Unoesc), Joaçaba, Brazil.
ORCID-Profile: Camila de Oliveira Vian
Förderung
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - Brazil (CAPES) - Finance code 001
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
Zitieren
APA
de Oliveira Vian, C., Marinho, M. A. G., da Silva Marques, M., Hort, M. A., Cordeiro, M. F., & Horn, A. P. (2024). Effects of quercetin in preclinical models of Parkinson's disease: A systematic review. Basic & Clinical Pharmacology & Toxicology. https://doi.org/10.1111/bcpt.14011
Vancouver
de Oliveira Vian C, Marinho MAG, da Silva Marques M, Hort MA, Cordeiro MF, Horn AP. Effects of quercetin in preclinical models of Parkinson's disease: A systematic review. Basic & Clinical Pharmacology & Toxicology. 2024. doi:10.1111/bcpt.14011
BibTeX
@article{deOliveiraVian2024,
author = {de Oliveira Vian, Camila and Marinho, Marcelo Augusto Germani and da Silva Marques, Magno and Hort, Mariana Appel and Cordeiro, Marcos Freitas and Horn, Ana Paula},
title = {Effects of quercetin in preclinical models of Parkinson's disease: A systematic review},
journal = {Basic & Clinical Pharmacology & Toxicology},
year = {2024},
doi = {10.1111/bcpt.14011}
}
EUVIMED